205 Users Online
Orally Disintegrating Tablet Market Segmented By Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensives, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitors Drug Class with CNS Diseases, GI Diseases, CVS Disorders, Allergy Disease Indication
1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Dynamics
3.1. Macro-Economic Factors
3.2. Drivers
3.2.1. Supply Side Drivers
3.2.2. Demand Side Drivers
3.3. Restraints
3.4. Opportunities
3.5. Trends
4. Key Inclusion
4.1. Formulation processes for Orally Disintegrating Tablets
4.2. Value Chain Analysis
5. Global Orally Disintegrating Tablets Market Value Analysis 2012-2021 and Forecast, 2022-2025
5.1. Historical Market Value (US$ Mn) Analysis, 2012-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2025
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Drug Class
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2021
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2022 - 2025
6.3.1. Anti-Psychotics
6.3.2. Anti-Epileptic’s
6.3.3. CNS Stimulants
6.3.4. Anxiolytics
6.3.5. Anti-Parkinson Ian Drugs
6.3.6. Anti-Hypertensives
6.3.7. NSAIDS
6.3.8. Anti-Allergy Drugs
6.3.9. Proton Pump Inhibitor
6.3.10. Others
6.4. Market Attractiveness Analysis By Drug Class
7. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Disease Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2012-2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022 - 2025
7.3.1. Central Nervous System Diseases (CNS)
7.3.2. Gastrointestinal (GI) Diseases
7.3.3. Cardiovascular(CVS) Diseases
7.3.4. Allergy
7.3.5. Others
7.4. Market Attractiveness Analysis By Disease Indication
8. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2025
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy
8.3.3. Drug Stores
8.3.4. Online Pharmacy
8.4. Market Attractiveness Analysis By Distribution Channel
9. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2025
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia-Pacific
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis By Region
10. North America Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Drug Class
10.3.3. By Disease Indication
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis
10.5. Drivers & Restraints: Impact Analysis
10.6. Partial List of Players with Product Intensity Map By Country
11. Latin America Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Drug Class
11.3.3. By Disease Indication
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.5. Drivers & Restraints: Impact Analysis
11.6. Partial List of Players with Product Intensity Map By Country
12. Europe Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. U.K.
12.3.1.3. France
12.3.1.4. Italy
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. Rest of Europe
12.3.2. By Drug Class
12.3.3. By Disease Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Drivers & Restraints: Impact Analysis
12.6. Partial List of Players with Product Intensity Map By Country
13. Asia-Pacific Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025
13.3.1. By Country
13.3.1.1. China
13.3.1.2. India
13.3.1.3. Japan
13.3.1.4. Australia & New Zealand
13.3.1.5. Rest of Asia-Pacific
13.3.2. By Drug Class
13.3.3. By Disease Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Drivers & Restraints: Impact Analysis
13.6. Partial List of Players with Product Intensity Map By Country
14. Middle East and Africa Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025
14.3.1. By Country
14.3.1.1. GCC Countries
14.3.1.2. South Africa
14.3.1.3. Rest of MEA
14.3.2. By Drug Class
14.3.3. By Disease Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Drivers & Restraints: Impact Analysis
14.6. Partial List of Players with Product Intensity Map By Country
15. Competition Analysis
15.1. Company Share Analysis
15.2. Market Structure by Tier of Companies
15.3. Competition Dashboard
15.4. Competition Deep Dive
15.4.1. Teva Pharmaceutical Industries Ltd.
15.4.1.1. Company Overview
15.4.1.2. Segment Overview
15.4.1.3. Product Offerings
15.4.1.4. Financial Analysis
15.4.1.5. Key Developments
15.4.1.6. Strategy Overview
15.4.2. Novartis AG
15.4.2.1. Company Overview
15.4.2.2. Segment Overview
15.4.2.3. Product Offerings
15.4.2.4. Financial Analysis
15.4.2.5. Key Developments
15.4.2.6. Strategy Overview
15.4.3. AstraZeneca
15.4.3.1. Company Overview
15.4.3.2. Segment Overview
15.4.3.3. Product Offerings
15.4.3.4. Financial Analysis
15.4.3.5. Key Developments
15.4.3.6. Strategy Overview
15.4.4. Mylan N.V.
15.4.4.1. Company Overview
15.4.4.2. Segment Overview
15.4.4.3. Product Offerings
15.4.4.4. Financial Analysis
15.4.4.5. Key Developments
15.4.4.6. Strategy Overview
15.4.5. Pfizer Inc.
15.4.5.1. Company Overview
15.4.5.2. Segment Overview
15.4.5.3. Product Offerings
15.4.5.4. Financial Analysis
15.4.5.5. Key Developments
15.4.5.6. Strategy Overview
15.4.6. Johnson & Johnson Services, Inc.
15.4.6.1. Company Overview
15.4.6.2. Segment Overview
15.4.6.3. Product Offerings
15.4.6.4. Financial Analysis
15.4.6.5. Key Developments
15.4.6.6. Strategy Overview
15.4.7. F. Hoffmann-La Roche Ltd.
15.4.7.1. Company Overview
15.4.7.2. Segment Overview
15.4.7.3. Product Offerings
15.4.7.4. Financial Analysis
15.4.7.5. Key Developments
15.4.7.6. Strategy Overview
15.4.8. Merck & Co., Inc.
15.4.8.1. Company Overview
15.4.8.2. Segment Overview
15.4.8.3. Product Offerings
15.4.8.4. Financial Analysis
15.4.8.5. Key Developments
15.4.8.6. Strategy Overview
15.4.9. Bausch Health
15.4.9.1. Company Overview
15.4.9.2. Segment Overview
15.4.9.3. Product Offerings
15.4.9.4. Financial Analysis
15.4.9.5. Key Developments
15.4.9.6. Strategy Overview
15.4.10. GlaxoSmithKline plc.
15.4.10.1. Company Overview
15.4.10.2. Segment Overview
15.4.10.3. Product Offerings
15.4.10.4. Financial Analysis
15.4.10.5. Key Developments
15.4.10.6. Strategy Overview
15.4.11. Sun Pharmaceutical Industries Ltd.
15.4.11.1. Company Overview
15.4.11.2. Segment Overview
15.4.11.3. Product Offerings
15.4.11.4. Financial Analysis
15.4.11.5. Key Developments
15.4.11.6. Strategy Overview
15.4.12. Bayer AG
15.4.12.1. Company Overview
15.4.12.2. Segment Overview
15.4.12.3. Product Offerings
15.4.12.4. Financial Analysis
15.4.12.5. Key Developments
15.4.12.6. Strategy Overview
15.4.13. Eli Lily and Company
15.4.13.1. Company Overview
15.4.13.2. Segment Overview
15.4.13.3. Product Offerings
15.4.13.4. Financial Analysis
15.4.13.5. Key Developments
15.4.13.6. Strategy Overview
15.4.14. Dr. Reddy’s Laboratories Ltd.
15.4.14.1. Company Overview
15.4.14.2. Segment Overview
15.4.14.3. Product Offerings
15.4.14.4. Financial Analysis
15.4.14.5. Key Developments
15.4.14.6. Strategy Overview
15.4.15. Takeda Pharmaceutical Company Limited
15.4.15.1. Company Overview
15.4.15.2. Segment Overview
15.4.15.3. Product Offerings
15.4.15.4. Financial Analysis
15.4.15.5. Key Developments
15.4.15.6. Strategy Overview
16. Assumptions and Acronyms Used
17. Research Methodology
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class
Table 02: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication
Table 03: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel
Table 04: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Region
Table 05: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country
Table 06: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class
Table 07: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication
Table 08: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel
Table 09: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country
Table 10: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class
Table 11: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication
Table 12: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel
Table 13: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country
Table 14: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class
Table 15: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication
Table 16: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel
Table 17: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country
Table 18: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class
Table 19: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication
Table 20: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel
Table 21: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country
Table 22: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class
Table 23: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication
Table 24: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Orally Disintegrating Tablets Market Split By Drug Class (2022E)
Figure 02: Global Orally Disintegrating Tablets Market Split By Disease Indication (2022E)
Figure 03: Global Orally Disintegrating Tablets Market Split By Distribution Channel (2022E)
Figure 04: Global Orally Disintegrating Tablets Market Split By Region (2022E)
Figure 05: Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021
Figure 06: Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025
Figure 07: Orally Disintegrating Tablets Market Absolute $ Opportunity, 2022–2025
Figure 08: Orally Disintegrating Tablets Market Share Analysis (%), By Drug Class, 2022 & 2025
Figure 09: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Drug Class, 2022–2025
Figure 10: Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class, 2022–2025
Figure 11: Orally Disintegrating Tablets Market Share Analysis (%), By Disease Indication, 2022 & 2025
Figure 12: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Disease Indication, 2022–2025
Figure 13: Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025
Figure 14: Orally Disintegrating Tablets Market Share Analysis (%), By Distribution Channel, 2022 & 2025
Figure 15: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Distribution Channel, 2022–2025
Figure 16: Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025
Figure 17: Orally Disintegrating Tablets Market Share Analysis (%), By Region, 2022 & 2025
Figure 18: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Region, 2022–2025
Figure 19: Orally Disintegrating Tablets Market Attractiveness Analysis by Region, 2022–2025
Figure 20: North America Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)
Figure 21: North America Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)
Figure 22: North America Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)
Figure 23: North America Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)
Figure 24: North America Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021
Figure 25: North America Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025
Figure 26: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2022–2025
Figure 27: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025
Figure 28: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025
Figure 29: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025
Figure 30: Latin America Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)
Figure 31: Latin America Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)
Figure 32: Latin America Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)
Figure 33: Latin America Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)
Figure 34: Latin America Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021
Figure 35: Latin America Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025
Figure 36: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2022–2025
Figure 37: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025
Figure 38: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025
Figure 39: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025
Figure 40: Europe Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)
Figure 41: Europe Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)
Figure 42: Europe Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)
Figure 43: Europe Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)
Figure 44: Europe Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021
Figure 45: Europe Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025
Figure 46: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2022–2025
Figure 47: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025
Figure 48: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025
Figure 49: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025
Figure 50: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)
Figure 51: Asia-Pacific Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)
Figure 52: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)
Figure 53: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)
Figure 54: Asia-Pacific Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021
Figure 55: Asia-Pacific Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025
Figure 56: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2022–2025
Figure 57: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025
Figure 58: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025
Figure 59: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025
Figure 60: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)
Figure 61: Middle East & Africa Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)
Figure 62: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)
Figure 63: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)
Figure 64: Middle East & Africa Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021
Figure 65: Middle East & Africa Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025
Figure 66: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class, 2022–2025
Figure 67: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025
Figure 68: MEA Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel, 2022–2025
Figure 69: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis, By Country, 2022–2025
Figure 70: Orally Disintegrating Tablets Market: Company Share Analysis Share Analysis (2022)
